CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceuticals company that develops targeted anticancer therapeutics using its Tumor-Activated Prodrug (TAP) technology, invites investors, journalists and the general public to listen to a live webcast of the Company's investment community meeting on August 9, 2007. The webcast will begin at 8:30 am ET and may be accessed through the investor relations section of the Company's website, www.immunogen.com. The meeting is expected to last approximately three hours, including a short break. An archive of the webcast will be available on the Company's website through August 23, 2007.
